{"id":10514,"date":"2022-03-24T15:59:20","date_gmt":"2022-03-24T19:59:20","guid":{"rendered":"https:\/\/www.silverlaw.com\/blog\/?p=10514"},"modified":"2022-03-24T15:59:20","modified_gmt":"2022-03-24T19:59:20","slug":"marker-therapeutics-loses-case-to-katalyst-securities","status":"publish","type":"post","link":"https:\/\/www.silverlaw.com\/blog\/marker-therapeutics-loses-case-to-katalyst-securities\/","title":{"rendered":"Marker Therapeutics Loses Case To Katalyst Securities"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft wp-image-10372 size-full\" src=\"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2022\/01\/FiverRecoverysmall.jpg\" alt=\"New York U.S. District Judge Laura T. Swain has ordered Marker Therapeutics to pay $2.5 million to Katalyst Securities, a brokerage that helped place their securities with their own investor-customers as a private placement in 2017. Additionally, Judge Swain also ordered Marker to pay about $120,000 in prejudgment interest.  The company signed a contract with Katalyst for two private placements in 2016 and 2017, establishing a placement agency to offer these placements to the investor-customers in exchange for fees and warrants to buy shares of Marker's stock. A one-year \u201ctail period\u201d and additional compensation was included in the contract for Katalyst if they brought in more investors and completed financing during that period. Marker later hired two other companies in 2018 for the same type of work.  Katalyst accused Marker of securing financing for investors that were introduced to Marker by Katalyst during the tail period. In a motion filed by Maker, the company claimed that Katalyst had already been paid and the tail period had expired. Katalyst also sent Marker a proposed modification to the remaining agreement to continue the tail period and include the 2018 offering. Maker declined, stating that the 2018 offering was outside of Katalyst\u2019s one-year tail period. Therefore, Katalyst wasn\u2019t eligible to receive to any more of the offerings. Katalyst then began the process for arbitration, according to Maker.\" width=\"300\" height=\"200\" srcset=\"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2022\/01\/FiverRecoverysmall.jpg 300w, https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2022\/01\/FiverRecoverysmall-180x120.jpg 180w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/>New York U.S. District Judge Laura T. Swain has ordered Marker Therapeutics to pay $2.5 million to Katalyst Securities, a brokerage that helped place their securities with their own investor-customers as a private placement in 2017. Additionally, Judge Swain also ordered Marker to pay about $120,000 in prejudgment interest. <a href=\"https:\/\/www.silverlaw.com\/blog\/marker-therapeutics-loses-case-to-katalyst-securities\/#more-10514\" class=\"more-link\">Continue reading \u203a<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>New York U.S. District Judge Laura T. Swain has ordered Marker Therapeutics to pay $2.5 million to Katalyst Securities, a brokerage that helped place their securities with their own investor-customers as a private placement in 2017. Additionally, Judge Swain also ordered Marker to pay about $120,000 in prejudgment interest. Continue reading \u203a<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[602],"tags":[],"class_list":["post-10514","post","type-post","status-publish","format-standard","hentry","category-class-action"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Marker Therapeutics Loses Case To Katalyst Securities &#8212;<\/title>\n<meta name=\"description\" content=\"A judge has ordered Marker Therapeutics to pay $2.5 million to Katalyst Securities, a brokerage that helped place their securities.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.silverlaw.com\/blog\/marker-therapeutics-loses-case-to-katalyst-securities\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Marker Therapeutics Loses Case To Katalyst Securities &#8212;\" \/>\n<meta name=\"twitter:description\" content=\"A judge has ordered Marker Therapeutics to pay $2.5 million to Katalyst Securities, a brokerage that helped place their securities.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2022\/01\/FiverRecoverysmall.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Silver Law Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Marker Therapeutics Loses Case To Katalyst Securities &#8212;","description":"A judge has ordered Marker Therapeutics to pay $2.5 million to Katalyst Securities, a brokerage that helped place their securities.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.silverlaw.com\/blog\/marker-therapeutics-loses-case-to-katalyst-securities\/","twitter_card":"summary_large_image","twitter_title":"Marker Therapeutics Loses Case To Katalyst Securities &#8212;","twitter_description":"A judge has ordered Marker Therapeutics to pay $2.5 million to Katalyst Securities, a brokerage that helped place their securities.","twitter_image":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2022\/01\/FiverRecoverysmall.jpg","twitter_misc":{"Written by":"Silver Law Group","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.silverlaw.com\/blog\/marker-therapeutics-loses-case-to-katalyst-securities\/#article","isPartOf":{"@id":"https:\/\/www.silverlaw.com\/blog\/marker-therapeutics-loses-case-to-katalyst-securities\/"},"author":{"name":"Silver Law Group","@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/de64d999508b1ad10d608a99f0d2e752"},"headline":"Marker Therapeutics Loses Case To Katalyst Securities","datePublished":"2022-03-24T19:59:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.silverlaw.com\/blog\/marker-therapeutics-loses-case-to-katalyst-securities\/"},"wordCount":562,"image":{"@id":"https:\/\/www.silverlaw.com\/blog\/marker-therapeutics-loses-case-to-katalyst-securities\/#primaryimage"},"thumbnailUrl":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2022\/01\/FiverRecoverysmall.jpg","articleSection":["Class Action"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.silverlaw.com\/blog\/marker-therapeutics-loses-case-to-katalyst-securities\/","url":"https:\/\/www.silverlaw.com\/blog\/marker-therapeutics-loses-case-to-katalyst-securities\/","name":"Marker Therapeutics Loses Case To Katalyst Securities &#8212;","isPartOf":{"@id":"https:\/\/www.silverlaw.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.silverlaw.com\/blog\/marker-therapeutics-loses-case-to-katalyst-securities\/#primaryimage"},"image":{"@id":"https:\/\/www.silverlaw.com\/blog\/marker-therapeutics-loses-case-to-katalyst-securities\/#primaryimage"},"thumbnailUrl":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2022\/01\/FiverRecoverysmall.jpg","datePublished":"2022-03-24T19:59:20+00:00","author":{"@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/de64d999508b1ad10d608a99f0d2e752"},"description":"A judge has ordered Marker Therapeutics to pay $2.5 million to Katalyst Securities, a brokerage that helped place their securities.","breadcrumb":{"@id":"https:\/\/www.silverlaw.com\/blog\/marker-therapeutics-loses-case-to-katalyst-securities\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.silverlaw.com\/blog\/marker-therapeutics-loses-case-to-katalyst-securities\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.silverlaw.com\/blog\/marker-therapeutics-loses-case-to-katalyst-securities\/#primaryimage","url":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2022\/01\/FiverRecoverysmall.jpg","contentUrl":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2022\/01\/FiverRecoverysmall.jpg","width":300,"height":200},{"@type":"BreadcrumbList","@id":"https:\/\/www.silverlaw.com\/blog\/marker-therapeutics-loses-case-to-katalyst-securities\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.silverlaw.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Marker Therapeutics Loses Case To Katalyst Securities"}]},{"@type":"WebSite","@id":"https:\/\/www.silverlaw.com\/blog\/#website","url":"https:\/\/www.silverlaw.com\/blog\/","name":"Securities Arbitration Lawyers Blog","description":"Published by Securities Arbitration Lawyers \u2014 Silver Law Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.silverlaw.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/de64d999508b1ad10d608a99f0d2e752","name":"Silver Law Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/9eb0a691642ae95c68ee1c45b5f50f35bae76a41f3d9f861c7bfd40c87661746?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9eb0a691642ae95c68ee1c45b5f50f35bae76a41f3d9f861c7bfd40c87661746?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9eb0a691642ae95c68ee1c45b5f50f35bae76a41f3d9f861c7bfd40c87661746?s=96&d=mm&r=g","caption":"Silver Law Group"}}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts\/10514","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/comments?post=10514"}],"version-history":[{"count":2,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts\/10514\/revisions"}],"predecessor-version":[{"id":10516,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts\/10514\/revisions\/10516"}],"wp:attachment":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/media?parent=10514"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/categories?post=10514"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/tags?post=10514"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}